Eli Lilly and Company logo LLY - Eli Lilly and Company

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 32
HOLD 10
SELL 2
STRONG
SELL
0
| PRICE TARGET: $1151.07 DETAILS
HIGH: $1300.00
LOW: $830.00
MEDIAN: $1191.00
CONSENSUS: $1151.07
UPSIDE: 10.85%

About Eli Lilly and Company (https://www.lilly.com)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Key Executives

NAME TITLE DOB SALARY
David A. Ricks Chairman, Chief Executive Officer & President 1968 $7,747,119 USD
Daniel Skovronsky Chief Scientific & Product Officer and President of Lilly Research Laboratories 1973 $4,856,979 USD
Anat Hakim Executive VP, General Counsel & Secretary 1969 $3,316,834 USD
Jacob S. Van Naarden Executive VP & President of Lilly Oncology 1985 $3,006,813 USD
Lucas E. Montarce Executive VP & CFO 1977 $1,819,075 USD
Jeffrey N. Simmons Senior VP & President of Elanco Animal Health 1967 $1,729,146 USD
Gordon Brooks Group VP, Controller & Corporate Strategy $1,309,448 USD
Diogo Rau EVP & Chief Information and Digital Officer 1975 $1,056,809 USD
Donald A. Zakrowski Senior VP of Finance & Chief Accounting Officer
Eric Dozier Executive VP & Chief People Officer 1967